In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

Member Benefit

This content is only available year-round to EACVI Silver Members, Fellows of the ESC and Young combined Members

Myocardial native T1 mapping and correlations with clinical and CMR parameters in patients with systemic sclerosis

Session ePoster session

Speaker Antonella Meloni

Event : EACVI Best of Imaging 2020

  • Topic : imaging
  • Sub-topic : T1 and T2 Mapping
  • Session type : ePosters

Authors : A Meloni (Pisa,IT), L Gargani (Pisa,IT), C Bruni (Florence,IT), C Cavallaro (Rome,IT), M Gobbo (Trieste,IT), G D'angelo (Pisa,IT), N Martini (Pisa,IT), F Grigioni (Rome,IT), G Sinagra (Trieste,IT), S Mavrogeni (Athens,GR), M Matucci-Cerinic (Florence,IT), A Pepe (Pisa,IT)

Authors:
A Meloni1 , L Gargani2 , C Bruni3 , C Cavallaro4 , M Gobbo5 , G D'angelo2 , N Martini1 , F Grigioni4 , G Sinagra5 , S Mavrogeni6 , M Matucci-Cerinic3 , A Pepe1 , 1Fondazione Toscana Gabriele Monasterio - Pisa - Italy , 2National Council of Research - Pisa - Italy , 3University of Florence - Florence - Italy , 4Campus Bio-Medico University Of Rome - Rome - Italy , 5University of Trieste - Trieste - Italy , 6Onassis Cardiac Surgery Center - Athens - Greece ,

Topic(s):
T1 and T2 Mapping, T2*

Background: Systemic sclerosis (SSc) is a connective tissue disease characterized by diffuse vascular lesions and fibrosis, also affecting the heart. Cardiovascular magnetic resonance (CMR) can detect replacement myocardial fibrosis by late gadolinium enhancement (LGE) and interstitial myocardial fibrosis/edema by T1 mapping techniques.

Purpose: To evaluate the prevalence of cardiac involvement by native T1 mapping and its correlation with clinical and CMR parameters in SSc patients.

Methods: Fifty-one consecutive SSc patients (mean age 51.8±13.7 years, 42 females) and 51 healthy subjects matched for age and sex underwent clinical, bio-humoral assessment, and CMR at 1.5T (Signa Artist, GE Healthcare ). The imaging protocol included: cine, T1 mapping by MOLLI, T2 mapping by multi-echo fast-spin-echo sequence, LGE, and STIR T2-weighted sequences. Native T1 and T2 values were assessed in all 16 myocardial segments and the global value was the mean.

Results. Global native T1 values were significantly higher in SSc patients than in healthy subjects (1076.4±50.7 vs 1033.3±31.9 ms; P<0.0001).
As in healthy subjects, in patients native T1 values were significantly lower in males than in females (1033.4±38.3 vs 1085.6±48.6 ms; P=0.004) and inversely correlated with age (R=-0415; P=0.002).
Twenty-three (45.1%) patients had an increased global heart T1 value (>1060 ms in males and >1085 ms in females). Of them, 14 patients (60.9 %) showed positive LGE. Frequency of cardiovascular risk factors, indices of disease activity and chronicity, biochemical parameters, and cardio-active therapy were comparable between patients with normal and elevated T1. Compared to patients with normal T1 value, patients with elevated T1 had significantly higher left ventricular (LV) end-diastolic volume index (76.8±13.3 vs 69.2±11.8, P=0.050), LV stroke volume index (49.7±6.4 vs 44.4±6.9 ml/m2; P=0.010), LV cardiac output (3.6±0.5  vs 3.0±0.6 l/min /m2; P<0.0001), and global heart T2 values (60.1±3.6 vs 55.7±3.1 ms; P<0.0001).
Replacement myocardial fibrosis was detected in 24 (47.1%) patients and they showed significantly higher global heart native T1 values (Figure 1A).
Positive T2-weighted images for myocardial oedema were found in 5 (9.8%) patients, all with increased global heart native T1 value. Patients with oedema had significantly higher native global heart T1 values (Figure 1B).

Conclusion: Elevated native T1 values measured by CMR are frequent in SSc patients and they are associated with inflammation, replacement fibrosis, and increased LV dimension. CMR T1 mapping seems to be a sensitive parameter to include in the routine clinical assessment of SSc patients for detecting earlier pejorative cardiac involvement, although prospective data are recommended.

Member Benefit

This content is only available year-round to EACVI Silver Members, Fellows of the ESC and Young combined Members

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are